REFR — Research Frontiers Share News
0.000.00%
Last trade - 00:00- $15.62m
- $14.53m
- $1.12m
Research Frontiers Q1 net loss widens as revenue falls
Only gauze and iodine for injured patients at Gaza field hospital
Brief: Research Frontiers Reports Third Quarter 2022 Financial Results
Brief: Research Frontiers Reports First Quarter 2022 Financial Results
Brief: Research Frontiers Reports Fourth Quarter And Full Year 2021 Financial Results
Brief: Research Frontiers - Following Successfully Raising $60 Million In A Series D Financing, Gauzy Has Acquired Research Frontiers Licensee, Vision Systems
Brief: Research Frontiers Reports First Quarter 2021 Financial Results
Brief: PDS Biotechnology Appoints Seth Van Voorhees As Chief Financial Officer
Brief: Research Frontiers Inc Says CFO Seth Van Voorhees Resigned His Position
Brief: Research Frontiers Reports Third Quarter 2020 Financial Results
NASDAQ RESUMED AT 10:57 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:47 AM
Brief: Research Frontiers Reports QTRLY Loss Per Share Of $ 0.01
Brief: Research Frontiers Added To Russell 2000® Index
Brief: Research Frontiers Says Current Cash And Will Fund Its Operations For At Least Next 36 Months
Brief: Research Frontiers’ SPD-SmartGlass Licensed To Glatic
Brief: Research Frontiers Posts Q3 Loss Per Share Of $0.01
Brief: Research Frontiers Board Extends Joseph Harary's Employment As President, CEO And General Counsel For An Additional 5 Years
Brief: Research Frontiers Reports Qtrly Loss Per Share $0.05